Biochemistry of bacterial multidrug efflux pumps

International Journal of Molecular Sciences

Volumn 13, Issue 4, 2012, Pages 4484-4495

  Kumar, Sanath ^a   Varela, Manuel F ^b  

^a CENTRAL INSTITUTE OF FISHERIES EDUCATION   (India)

^b EASTERN NEW MEXICO UNIVERSITY   (United States)

Author keywords

Antibiotic resistance; Antiporter; Efflux pump; MFS; QaC; TET

Indexed keywords

BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; EMRD 3 PROTEIN; ERYTHROMYCIN; FLORFENICOL; LINCOSAMIDE DERIVATIVE; LMRS PROTEIN; MACROLIDE; MAJOR FACILITATOR SUPERFAMILY; MDFA PROTEIN; MDT(A) PROTEIN; NORA PROTEIN; NORB PROTEIN; NORC PROTEIN; NORFLOXACIN; QACA PROTEIN; QACB PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; STREPTOGRAMIN DERIVATIVE; TETA PROTEIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIPORTER; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; BACTERIAL MEMBRANE; DRUG TRANSPORT; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LACTOCOCCUS; LACTOCOCCUS GARVIEAE; LACTOCOCCUS LACTIS; MULTIDRUG RESISTANCE; NONHUMAN; REVIEW; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; VIBRIO CHOLERAE; BACTERIAL INFECTIONS; BACTERIUM; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY;

ANTI-BACTERIAL AGENTS; ANTIPORTERS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; VIRULENCE FACTORS;

EID: 84860163257     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13044484     Document Type: Review

References (94)

1. Drews, T.D.; Temte, J.L.; Fox, B.C. Community-associated methicillin-resistant Staphylococcus aureus: review of an emerging public health concern. Wis. Med. J. 2006, 105, 52-57.
2. Mandal, S.; Mandal, M.D.; Pal, N.K. Cholera: A great global concern. Asian Pac. J. Trop. Med. 2011, 4, 573-580.
3. Walsh, T.J.; Standiford, H.C.; Reboli, A.C.; John, J.F.; Mulligan, M.E.; Ribner, B.S.; Montgomerie, J.Z.; Goetz, M.B.; Mayhall, C.G.; Rimland, D.; et al. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: Prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob. Agents Chemother. 1993, 37, 1334-1342.
4. Walsh, C.T.; Fischbach, M.A. New ways to squash superbugs. Sci. Am. 2009, 301, 44-51.
5. Kitaoka, M.; Miyata, S.T.; Unterweger, D.; Pukatzki, S. Antibiotic resistance mechanisms of Vibrio cholerae. J. Med. Microbiol. 2011, 60, 397-407.
6. Prabaker, K.; Weinstein, R.A. Trends in antimicrobial resistance in intensive care units in the United States. Curr. Opin. Crit. Care 2011, 17, 472-479.
7. Levy, S.B. The challenge of antibiotic resistance. Sci. Am. 1998, 278, 46-53.
8. Levy, S.B. Antibiotic resistance-the problem intensifies. Adv. Drug Deliv. Rev. 2005, 57, 1446-1450.
9. Lewis, K. Multidrug resistance pumps in bacteria: Variations on a theme. Trends Biochem. Sci. 1994, 19, 119-123.
10. Lewis, K. In search of natural substrates and inhibitors of MDR pumps. J. Mol. Microbiol. Biotechnol. 2001, 3, 247-254.
11. Wright, G.D. The antibiotic resistome: The nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 2007, 5, 175-186.
12. Piddock, L.J. Multidrug-resistance efflux pumps-Not just for resistance. Nat. Rev. Microbiol. 2006, 4, 629-636.
13. Nikaido, H. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 1996, 178, 5853-5859.
14. Saier, M.H., Jr.; Paulsen, I.T. Phylogeny of multidrug transporters. Semin. Cell Dev. Biol. 2001, 12, 205-213.
15. Putman, M.; van Veen, H.W.; Konings, W.N. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 2000, 64, 672-693.
16. Li, X.Z.; Nikaido, H. Efflux-mediated drug resistance in bacteria: An update. Drugs 2009, 69, 1555-1623.
17. Okusu, H.; Ma, D.; Nikaido, H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J. Bacteriol. 1996, 178, 306-308.
18. Paulsen, I.T.; Skurray, R.A.; Tam, R.; Saier, M.H., Jr.; Turner, R.J.; Weiner, J.H.; Goldberg, E.B.; Grinius, L.L. The SMR family: A novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol. Microbiol. 1996, 19, 1167-1175.
19. Morar, M.; Wright, G.D. The genomic enzymology of antibiotic resistance. Annu. Rev. Genet. 2010, 44, 25-51.
20. Paulsen, I.T. Multidrug efflux pumps and resistance: Regulation and evolution. Curr. Opin. Microbiol. 2003,6, 446-451.
21. Cui, J.; Davidson, A.L. ABC solute importers in bacteria. Essay. Biochem. 2011, 50, 85-99.
22. Saier, M.H., Jr.; Beatty, J.T.; Goffeau, A.; Harley, K.T.; Heijne, W.H.; Huang, S.C.; Jack, D.L.; Jahn, P.S.; Lew, K.; Liu, J.; et al. The major facilitator superfamily. J. Mol. Microbiol. Biotechnol. 1999, 1, 257-279.
23. Nikaido, H.; Takatsuka, Y. Mechanisms of RND multidrug efflux pumps. Biochim. Biophys. Acta 2009, 1794, 769-781.
24. Griffith, J.K.; Baker, M.E.; Rouch, D.A.; Page, M.G.; Skurray, R.A.; Paulsen, I.T.; Chater, K.F.; Baldwin, S.A.; Henderson, P.J. Membrane transport proteins: Implications of sequence comparisons. Curr. Opin. Cell Biol. 1992, 4, 684-695.
25. He, G.X.; Thorpe, C.; Walsh, D.; Crow, R.; Chen, H.; Kumar, S.; Varela, M.F. EmmdR, a new member of the MATE family of multidrug transporters, extrudes quinolones from Enterobacter cloacae. Arch. Microbiol. 2011, 193, 759-765.
26. He, G.X.; Zhang, C.; Crow, R.R.; Thorpe, C.; Chen, H.; Kumar, S.; Tsuchiya, T.; Varela, M.F. SugE, a new member of the SMR family of transporters, contributes to antimicrobial resistance in Enterobacter cloacae. Antimicrob. Agents Chemother. 2011, 55, 3954-3957.
27. Henderson, P.J.; Roberts, P.E.; Martin, G.E.; Seamon, K.B.; Walmsley, A.R.; Rutherford, N.G.; Varela, M.F.; Griffith, J.K. Homologous sugar-transport proteins in microbes and man. Biochem. Soc. Trans. 1993, 21, 1002-1006.
28. Levy, S.B.; McMurry, L. Detection of an inducible membrane protein associated with R-factor-mediated tetracycline resistance. Biochem. Biophys. Res. Commun. 1974, 56, 1060-1068.
29. Levy, S.B.; McMurry, L. Plasmid-determined tetracycline resistance involves new transport systems for tetracycline. Nature 1978, 276, 90-92.
30. Levy, S.B. Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 1992, 36, 695-703.
31. Varela, M.F.; Griffith, J.K. Nucleotide and deduced protein sequences of the class D tetracycline resistance determinant: Relationship to other antimicrobial transport proteins. Antimicrob. Agents Chemother. 1993, 37, 1253-1258.
32. Varela, M.F.; Sansom, C.E.; Griffith, J.K. Mutational analysis and molecular modelling of an amino acid sequence motif conserved in antiporters but not symporters in a transporter superfamily. Mol. Membr. Biol. 1995, 12, 313-319.
33. Levy, S.B. Active efflux, a common mechanism for biocide and antibiotic resistance. Symp. Ser. Soc. Appl. Microbiol. 2002, 31, 65S-71S.
34. Kaneko, M.; Yamaguchi, A.; Sawai, T. Energetics of tetracycline efflux system encoded by Tn10 in Escherichia coli. FEBS Lett. 1985, 193, 194-198.
35. Chopra, I.; Hawkey, P.M.; Hinton, M. Tetracyclines, molecular and clinical aspects. J. Antimicrob. Chemother. 1992, 29, 245-277.
36. Guay, G.G.; Tuckman, M.; McNicholas, P.; Rothstein, D.M. The tet(K) gene from Staphylococcus aureus mediates the transport of potassium in Escherichia coli. J. Bacteriol. 1993, 175, 4927-4929.
37. Schwarz, S.; Cardoso, M.; Wegener, H.C. Nucleotide sequence and phylogeny of the tet(L) tetracycline resistance determinant encoded by plasmid pSTE1 from Staphylococcus hyicus. Antimicrob. Agents Chemother. 1992, 36, 580-588.
38. Henderson, P.J.; Maiden, M.C. Homologous sugar transport proteins in Escherichia coli and their relatives in both prokaryotes and eukaryotes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1990, 326, 391-410.
39. Maiden, M.C.; Davis, E.O.; Baldwin, S.A.; Moore, D.C.; Henderson, P.J. Mammalian and bacterial sugar transport proteins are homologous. Nature 1987, 325, 641-643.
40. Marger, M.D.; Saier, M.H., Jr. A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem. Sci. 1993, 18, 13-20.
41. Baldwin, S.A.; Henderson, P.J. Homologies between sugar transporters from eukaryotes and prokaryotes. Annu. Rev. Physiol. 1989, 51, 459-471.
42. Sheridan, R.P.; Chopra, I. Origin of tetracycline efflux proteins: Conclusions from nucleotide sequence analysis. Mol. Microbiol. 1991, 5, 895-900.
43. Lomovskaya, O.; Lewis, K. Emr, an Escherichia coli locus for multidrug resistance. Proc. Natl. Acad. Sci. USA 1992, 89, 8938-8942.
44. Neyfakh, A.A. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob. Agents Chemother. 1992, 36, 484-485.
45. De Jesus, M.; Jin, J.; Guffanti, A.A.; Krulwich, T.A. Importance of the GP dipeptide of the antiporter motif and other membrane-embedded proline and glycine residues in tetracycline efflux protein Tet(L). Biochemistry 2005, 44, 12896-12904.
46. + antiporters: Characterization of multiple catalytic modes and a mutagenesis approach to differences in their efflux substrate and coupling ion preferences. J. Bacteriol. 2002, 184, 4722-4732.
47. + transport. Eukaryot. Cell 2007, 6, 443-453.
48. Walther, C.; Rossano, A.; Thomann, A.; Perreten, V. Antibiotic resistance in Lactococcus species from bovine milk: Presence of a mutated multidrug transporter mdt(A) gene in susceptible Lactococcus garvieae strains. Vet. Microbiol. 2008, 131, 348-357
49. Hassan, K.A.; Galea, M.; Wu, J.; Mitchell, B.A.; Skurray, R.A.; Brown, M.H. Functional effects of intramembranous proline substitutions in the staphylococcal multidrug transporter QacA. FEMS Microbiol. Lett. 2006, 263, 76-85.
50. Chandrasekaran, A.; Ojeda, A.M.; Kolmakova, N.G.; Parsons, S.M. Mutational and bioinformatics analysis of proline- and glycine-rich motifs in vesicular acetylcholine transporter. J. Neurochem. 2006, 98, 1551-1559.
51. Perreten, V.; Schwarz, F.V.; Teuber, M.; Levy, S.B. Mdt(A), a new efflux protein conferring multiple antibiotic resistance in Lactococcus lactis and Escherichia coli. Antimicrob. Agents Chemother. 2001, 45, 1109-1114.
52. (+) antiporter from Staphylococcus aureus: Mutagenesis and functional analysis of motif C. J. Bacteriol. 2000, 182, 1492-1498.
53. Saraceni-Richards, C.A.; Levy, S.B. Second-site suppressor mutations of inactivating substitutions at gly247 of the tetracycline efflux protein, Tet(B). J. Bacteriol. 2000, 182, 6514-6516.
54. + antiport: Complete cysteine-scanning mutagenesis and the protein engineering approach. Curr. Opin. Chem. Biol. 2003, 7, 570-579.
55. Nelson, M.L.; Levy, S.B. Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein. Antimicrob. Agents Chemother. 1999, 43, 1719-1724.
56. Nelson, M.L.; Park, B.H.; Andrews, J.S.; Georgian, V.A.; Thomas, R.C.; Levy, S.B. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines. J. Med. Chem. 1993, 36, 370-377.
57. Nelson, M.L.; Park, B.H.; Levy, S.B. Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria. J. Med. Chem. 1994, 37, 1355-1361.
58. Wright, G.D.; Sutherland, A.D. New strategies for combating multidrug-resistant bacteria. Trends Mol. Med. 2007, 13, 260-267.
59. Rahman, M.M.; Garvey, M.; Piddock, L.J.; Gibbons, S. Antibacterial terpenes from the oleo-resin of Commiphora molmol (Engl.). Phytother. Res. 2008, 22, 1356-1360.
60. Edgar, R.; Bibi, E. A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA. EMBO J. 1999, 18, 822-832.
61. Adler, J.; Bibi, E. Membrane topology of the multidrug transporter MdfA: Complementary gene fusion studies reveal a nonessential C-terminal domain. J. Bacteriol. 2002, 184, 3313-3320.
62. Sigal, N.; Cohen-Karni, D.; Siemion, S.; Bibi, E. MdfA from Escherichia coli, a model protein for studying secondary multidrug transport. J. Mol. Microbiol. Biotechnol. 2006, 11, 308-317.
63. Begum, A.; Rahman, M.M.; Ogawa, W.; Mizushima, T.; Kuroda, T.; Tsuchiya, T. Gene cloning and characterization of four MATE family multidrug efflux pumps from Vibrio cholerae non-O1. Microbiol. Immunol. 2005, 49, 949-957.
64. Woolley, R.C.; Vediyappan, G.; Anderson, M.; Lackey, M.; Ramasubramanian, B.; Jiangping, B.; Borisova, T.; Colmer, J.A.; Hamood, A.N.; McVay, C.S.; et al. Characterization of the Vibrio cholerae vceCAB multiple-drug resistance efflux operon in Escherichia coli. J. Bacteriol. 2005, 187, 5500-5503.
65. Bina, X.R.; Provenzano, D.; Nguyen, N.; Bina, J.E. Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. Infect. Immun. 2008, 76, 3595-3605.
66. Smith, K.P.; Kumar, S.; Varela, M.F. Identification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395. Arch. Microbiol. 2009, 191, 903-911.
67. Zurenko, G.E.; Yagi, B.H.; Schaadt, R.D.; Allison, J.W.; Kilburn, J.O.; Glickman, S.E.; Hutchinson, D.K.; Barbachyn, M.R.; Brickner, S.J. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 1996, 40, 839-845.
68. Xiong, L.; Kloss, P.; Douthwaite, S.; Andersen, N.M.; Swaney, S.; Shinabarger, D.L.; Mankin, A.S. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action. J. Bacteriol. 2000, 82, 5325-5331
69. Bohnert, J.A.; Kern, W.V. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob. Agents Chemother. 2005, 49, 849-852.
70. Floyd, J.L.; Smith, K.P.; Kumar, S.H.; Floyd, J.T.; Varela, M.F. LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob. Agents Chemother. 2010, 54, 5406-5412.
71. Nishioka, T.; Ogawa, W.; Kuroda, T.; Katsu, T.; Tsuchiya, T. Gene cloning and characterization of EfmA, a multidrug efflux pump, from Enterococcus faecium. Biol. Pharm. Bull. 2009, 32, 483-488.
72. Tennent, J.M.; Lyon, B.R.; Midgley, M.; Jones, I.G.; Purewal, A.S.; Skurray, R.A. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J. Gen. Microbiol. 1989, 135, 1-10.
73. Mitchell, B.A.; Brown, M.H.; Skurray, R.A. QacA multidrug efflux pump from Staphylococcus aureus: Comparative analysis of resistance to diamidines, biguanidines, and guanylhydrazones. Antimicrob. Agents Chemother. 1998, 42, 475-477.
74. Rouch, D.A.; Cram, D.S.; DiBerardino, D.; Littlejohn, T.G.; Skurray, R.A. Efflux-mediated antiseptic resistance gene qacA from Staphylococcus aureus: Common ancestry with tetracycline- and sugar-transport proteins. Mol. Microbiol. 1990, 4, 2051-2062.
75. Brown, M.H.; Skurray, R.A. Staphylococcal multidrug efflux protein QacA. J. Mol. Microbiol. Biotechnol. 2001, 3, 163-170.
76. Saidijam, M.; Benedetti, G.; Ren, Q.; Xu, Z.; Hoyle, C.J.; Palmer, S.L.; Ward, A.; Bettaney, K.E.; Szakonyi, G.; Meuller, J.; et al. Microbial drug efflux proteins of the major facilitator superfamily. Curr. Drug Targets 2006, 7, 793-811.
77. Paulsen, I.T.; Lewis, K. Microbial multidrug efflux: Introduction. J. Mol. Microbiol. Biotechnol. 2001, 3, 143-144.
78. Mitchell, B.A.; Paulsen, I.T.; Brown, M.H.; Skurray, R.A. Bioenergetics of the staphylococcal multidrug export protein QacA. Identification of distinct binding sites for monovalent and divalent cations. J. Biol. Chem. 1999, 274, 3541-3548.
79. Paulsen, I.T.; Brown, M.H.; Littlejohn, T.G.; Mitchell, B.A.; Skurray, R.A. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: Membrane topology and identification of residues involved in substrate specificity. Proc. Natl. Acad. Sci. USA 1996, 93, 3630-3635.
80. Jia, B.; Zhou, T.Q.; Huang, A.L.; Huang, W.X. Role of TMS5: Staphylococcal multidrug-efflux protein QacA. Chin. Med. J. (Engl.) 2008, 121, 409-413.
81. Hassan, K.A.; Skurray, R.A.; Brown, M.H. Transmembrane helix 12 of the Staphylococcus aureus multidrug transporter QacA lines the bivalent cationic drug binding pocket. J. Bacteriol. 2007, 189, 9131-9134.
82. Xu, Z.; O'Rourke, B.A.; Skurray, R.A.; Brown, M.H. Role of transmembrane segment 10 in efflux mediated by the staphylococcal multidrug transport protein QacA. J. Biol. Chem. 2006, 281, 792-799.
83. Wu, J.; Hassan, K.A.; Skurray, R.A.; Brown, M.H. Functional analyses reveal an important role for tyrosine residues in the staphylococcal multidrug efflux protein QacA. BMC Microbiol. 2008, 8, doi:10.1186/1471-2180-8-147.
84. Hassan, K.A.; Souhani, T.; Skurray, R.A.; Brown, M.H. Analysis of tryptophan residues in the staphylococcal multidrug transporter QacA reveals long-distance functional associations of residues on opposite sides of the membrane. J. Bacteriol. 2008, 190, 2441-2449.
85. Hassan, K.A.; Skurray, R.A.; Brown, M.H. Active export proteins mediating drug resistance in staphylococci. J. Mol. Microbiol. Biotechnol. 2007, 12, 180-196.
86. Grkovic, S.; Brown, M.H.; Roberts, N.J.; Paulsen, I.T.; Skurray, R.A. QacR is a repressor protein that regulates expression of the Staphylococcus aureus multidrug efflux pump QacA. J. Biol. Chem. 1998, 273, 18665-18673.
87. Ubukata, K.; Itoh-Yamashita, N.; Konno, M. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 1989, 33, 1535-1539.
88. Yoshida, H.; Bogaki, M.; Nakamura, S.; Ubukata, K.; Konno, M. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 1990, 172, 6942-6949.
89. Truong-Bolduc, Q.C.; Dunman, P.M.; Strahilevitz, J.; Projan, S.J.; Hooper, D.C. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J. Bacteriol. 2005, 187, 2395-2405.
90. Ding, Y.; Onodera, Y.; Lee, J.C.; Hooper, D.C. NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses. J. Bacteriol. 2008, 190, 7123-7129.
91. Hirai, K.; Aoyama, H.; Suzue, S.; Irikura, T.; Iyobe, S.; Mitsuhashi, S. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob. Agents Chemother. 1986, 30, 248-253.
92. Saidijam, M.; Bettaney, K.E.; Leng, D.; Ma, P.; Xu, Z.; Keen, J.N.; Rutherford, N.G.; Ward, A.; Henderson, P.J.; Szakonyi, G.; et al. The MFS efflux proteins of gram-positive and gram-negative bacteria. Adv. Enzymol. Relat. Areas Mol. Biol. 2011, 77, 147-166.
93. Gootz, T.D. The global problem of antibiotic resistance. Crit. Rev. Immunol. 2010, 30,79-93
94. Kumar, A.; Schweizer, H.P. Bacterial resistance to antibiotics: Active efflux and reduced uptake. Adv. Drug Deliv. Rev. 2005, 57, 1486-1513.